FDA Approves Dyloject Injection for Pain Management

December 30, 2014 2:12 PM

15 0

(Reuters) - Hospira Inc said on Tuesday the U.S. Food and Drug Administration approved its injectable drug to manage moderate to severe pain. The drug, Dyloject, can be used alone, or in combination with non-opioid painkillers, the company said.

The FDA today approved Hospira Inc’s diclofenac sodium (Dyloject) injection, a proprietary nonsteroidal anti-inflammatory drug (NSAID) analgesic, for the treatment of mild to moderate pain or for the management of moderate to severe pain alone or in combination with opioid analgesics among adults.

Read more

To category page